CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
TOTAL REVENUE	$ 3,748	$ 9,588
COST OF GOODS SOLD	(2,602)	(3,085)
RESEARCH AND DEVELOPMENT EXPENSES	(2,887)	(5,847)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(3,115)	(3,115)
OPERATING LOSS	(4,856)	(2,459)
FINANCIAL EXPENSES	(390)	(649)
FINANCIAL INCOME	513	172
FINANCIAL INCOME (EXPENSES), NET	123	(477)
LOSS BEFORE TAX BENEFIT (TAXES ON INCOME)	(4,733)	(2,936)
TAX BENEFIT (TAXES ON INCOME)	138	(195)
NET LOSS FOR THE PERIOD	$ (4,595)	$ (3,131)
LOSS PER SHARE OF COMMON STOCK - BASIC	$ (0.06)	$ (0.05)
LOSS PER SHARE OF COMMON STOCK - DILUTED	$ (0.06)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE- BASIC	73,036,569	57,480,009
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE- DILUTED	73,036,569	57,480,009
Goods
TOTAL REVENUE	$ 3,677	$ 5,066
License and R&D Services
TOTAL REVENUE	$ 71	$ 4,522